Is Avalo Therapeutics, Inc. overvalued?

Avalo Therapeutics, Inc. (AVTX) — key valuation metrics and fundamentals.

No verdict

Price

$18.64

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$214.7M

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares AVTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.

Related stocks